{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:57:43Z","timestamp":1791233863817,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01-AI155696"],"award-info":[{"award-number":["R01-AI155696"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UG3TR003355"],"award-info":[{"award-number":["UG3TR003355"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG080246"],"award-info":[{"award-number":["AG080246"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG078185"],"award-info":[{"award-number":["R01AG078185"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG074273"],"award-info":[{"award-number":["R01AG074273"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG091126"],"award-info":[{"award-number":["AG091126"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG078635"],"award-info":[{"award-number":["AG078635"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01-GM138385"],"award-info":[{"award-number":["R01-GM138385"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK120515"],"award-info":[{"award-number":["P30 DK120515"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.09.022","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:00:24Z","timestamp":1790060424000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Catestatin peptide ameliorates tauopathy and amyloidogenesis via adrenergic inhibition"],"prefix":"10.1016","author":[{"given":"Suborno","family":"Jati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satadeepa","family":"Kal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Munoz-Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kechun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashis","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8300-9873","authenticated-orcid":false,"given":"Sushil K.","family":"Mahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.09.022_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/0115672050301407240408033046","article-title":"Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology","volume":"21","author":"Kalyaanamoorthy","year":"2024","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ymthe.2026.09.022_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12964-024-01791-8","article-title":"Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways","volume":"22","author":"Kosz\u0142a","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2026.09.022_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-051222-120750","article-title":"Neurodegenerative Disease Tauopathies","volume":"19","author":"Creekmore","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.022_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(24)00274-6","article-title":"Clinical versus biomarker-based diagnosis of neurocognitive disorders","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0306-4522(92)90222-N","article-title":"The chromogranins A and B: the first 25 years and future perspectives","volume":"49","author":"Winkler","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2026.09.022_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(91)90795-W","article-title":"Chromogranin A: localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve","volume":"567","author":"O'Connor","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2026.09.022_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/er.2010-0027","article-title":"The extended granin family: structure, function, and biomedical implications","volume":"32","author":"Bartolomucci","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ymthe.2026.09.022_bib9","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/s41467-025-59682-6","article-title":"Chromogranin A deficiency attenuates tauopathy by altering epinephrine-alpha-adrenergic receptor signaling in PS19 mice","volume":"16","author":"Jati","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.022_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-026-02286-y","article-title":"AI guided discovery of a murine model of asymptomatic Alzheimer's disease","volume":"14","author":"Jati","year":"2026","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2026.09.022_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.exger.2003.09.018","article-title":"Chromogranin peptides in Alzheimer's disease","volume":"39","author":"Lechner","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jalz.2009.12.005","article-title":"Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses","volume":"6","author":"Brunnstr\u00f6m","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ymthe.2026.09.022_bib13","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1172\/JCI119686","article-title":"Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist","volume":"100","author":"Mahata","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.09.022_bib14","first-page":"1525","article-title":"Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A344-364): Identification of amino acid residues crucial for activity","volume":"14","author":"Mahata","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2010.01.006","article-title":"Catestatin: a multifunctional peptide from chromogranin A","volume":"162","author":"Mahata","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ymthe.2026.09.022_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/324476a0","article-title":"Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion","volume":"324","author":"Tatemoto","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.022_bib17","doi-asserted-by":"crossref","first-page":"28498","DOI":"10.1074\/jbc.M109.020636","article-title":"A novel pathway of insulin sensitivity in chromogranin a null mice: A crucial role for pancreastatin in glucose homeostasis","volume":"284","author":"Gayen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.09.022_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/db13-1747","article-title":"Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance","volume":"64","author":"Bandyopadhyay","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ymthe.2026.09.022_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2826.1993.tb00501.x","article-title":"Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments","volume":"5","author":"Aardal","year":"1993","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib20","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI24354","article-title":"Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog","volume":"115","author":"Mahapatra","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.09.022_bib21","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/en.2008-0318","article-title":"The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine\/paracrine modulator of cardiac inotropism and lusitropism","volume":"149","author":"Angelone","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymthe.2026.09.022_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029470","article-title":"Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation","volume":"12","author":"Qiu","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ymthe.2026.09.022_bib23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2174\/0929867324666170425100416","article-title":"Catestatin: A Master Regulator of Cardiovascular Functions","volume":"25","author":"Mahata","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ymthe.2026.09.022_bib24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2337\/db17-0788","article-title":"Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity","volume":"67","author":"Ying","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.ymthe.2026.09.022_bib25","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1021\/acschemneuro.2c00222","article-title":"Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer's Disease Brain","volume":"13","author":"Podvin","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.022_bib26","article-title":"Pharmacologic inhibition of PCBP2 biomolecular condensates relieves Alzheimer's disease","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.022_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109267","article-title":"Design, Ssynthesis, and biological evaluation of beta-secretase inhibitors: An integrated study of molecular docking, dynamics, pharmacokinetics, quantum chemistry, and in-vitro analysis for Alzheimer's disease","volume":"167","author":"Patel","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ymthe.2026.09.022_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci15101101","article-title":"Therapeutic Advances in Targeting the Amyloid-beta Pathway for Alzheimer's Disease","volume":"15","author":"Zhang","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.ymthe.2026.09.022_bib29","doi-asserted-by":"crossref","first-page":"48887","DOI":"10.1021\/acsomega.5c07084","article-title":"Silodosin as a Novel Inhibitor of Acetylcholinesterase, Butyrylcholinesterase, and BETA-Secretase 1: In Vitro and In Silico Studies","volume":"10","author":"Barbosa","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ymthe.2026.09.022_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10787-025-02000-9","article-title":"Pharmacological modulation of the PI3K\/AKT\/GSK3beta axis: a new frontier in Alzheimer's disease treatment","volume":"34","author":"Alqahtani","year":"2026","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ymthe.2026.09.022_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.022_bib32","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer's Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.022_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41398-024-03118-0","article-title":"Davunetide sex-dependently boosts memory in prodromal Alzheimer's disease","volume":"14","author":"Gozes","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ymthe.2026.09.022_bib35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/hmg\/ddx052","article-title":"Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease","volume":"26","author":"Reddy","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.022_bib36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/ph5101103","article-title":"Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease","volume":"5","author":"Calkins","year":"2012","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ymthe.2026.09.022_bib37","article-title":"Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration. Front. Integr","volume":"15","author":"Nhu","year":"2021","journal-title":"Neurosci"},{"key":"10.1016\/j.ymthe.2026.09.022_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fnmol.2018.00493","article-title":"Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease","volume":"11","author":"Chen","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.022_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313086","article-title":"The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer's Disease","volume":"25","author":"J\u00e1szber\u00e9nyi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.09.022_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2021.11.002","article-title":"Putative regulation of macrophage-mediated inflammation by catestatin","volume":"43","author":"Muntjewerff","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib41","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s42003-025-09135-z","article-title":"Chromogranin A and catestatin regulate pancreatic islet homeostasis, endocrine function, and neurotransmitter signaling","volume":"8","author":"Muntjewerff","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib42","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/HYPERTENSIONAHA.120.16809","article-title":"Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin)","volume":"77","author":"Ying","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ymthe.2026.09.022_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2026.09.022_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-026-00628-y","article-title":"Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways","volume":"15","author":"Kal","year":"2026","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ymthe.2026.09.022_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-181263","article-title":"Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression","volume":"69","author":"Regalado-Reyes","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ymthe.2026.09.022_bib46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib47","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ymthe.2026.09.022_bib48","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3233\/JAD-180582","article-title":"Epitomic Characterization of the Specificity of the Anti-Amyloid Abeta Monoclonal Antibodies 6E10 and 4G8","volume":"66","author":"Baghallab","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ymthe.2026.09.022_bib49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. Data"},{"key":"10.1016\/j.ymthe.2026.09.022_bib50","doi-asserted-by":"crossref","first-page":"32058","DOI":"10.1074\/jbc.M305545200","article-title":"Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter\/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin","volume":"278","author":"Mahata","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.09.022_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/381399","article-title":"Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology","volume":"74","author":"Wen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.09.022_bib52","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.106.628859","article-title":"Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension","volume":"115","author":"Rao","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.09.022_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/310503a0","article-title":"DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1","volume":"310","author":"Hemmings","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.022_bib54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0026-895X(25)15265-6","article-title":"Effects of xanthine derivatives on lipolysis and on adenosine 3',5'-monophosphate phosphodiesterase activity","volume":"6","author":"Beavo","year":"1970","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib55","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.78.6.3363","article-title":"Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells","volume":"78","author":"Seamon","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.022_bib56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","article-title":"Corticobasal degeneration: a pathologically distinct 4R tauopathy","volume":"7","author":"Kouri","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib57","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","article-title":"Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials","volume":"28","author":"Basheer","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ymthe.2026.09.022_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ymthe.2026.09.022_bib59","doi-asserted-by":"crossref","DOI":"10.31083\/JIN39826","article-title":"Proteostasis and Neuroinflammation in Alzheimer's Disease","volume":"24","author":"Potokiri","year":"2025","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.022_bib60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-4-48","article-title":"Alzheimer's disease: synaptic dysfunction and Abeta","volume":"4","author":"Shankar","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2026.09.022_bib62","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12035-012-8324-3","article-title":"Targeting synaptic dysfunction in Alzheimer's disease therapy","volume":"46","author":"Nistic\u00f2","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2026.09.022_bib64","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.022_bib65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156720512799015037","article-title":"Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease","volume":"9","author":"de la Monte","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ymthe.2026.09.022_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib67","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1210\/jc.2005-0408","article-title":"Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism","volume":"90","author":"O'Connor","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2026.09.022_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-018-1855-6","article-title":"Tau seeding activity begins in the transentorhinal\/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART","volume":"136","author":"Kaufman","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib69","doi-asserted-by":"crossref","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","article-title":"Proteopathic tau seeding predicts tauopathy in vivo","volume":"111","author":"Holmes","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.022_bib70","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2014.04.001","article-title":"Antihypertensive and neuroprotective effects of catestatin in spontaneously hypertensive rats: Interaction with GABAergic transmission in amygdala and brainstem","volume":"270","author":"Avolio","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2026.09.022_bib71","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.022_bib72","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/biom15010128","article-title":"Deciphering the Role of Adrenergic Receptors in Alzheimer's Disease: Paving the Way for Innovative Therapies","volume":"15","author":"Miliotou","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2026.09.022_bib73","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/hmg\/ddu116","article-title":"Genetic suppression of beta2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies","volume":"23","author":"Wisely","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.022_bib74","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1042\/bj3160655","article-title":"Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium\/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356","volume":"316","author":"Litersky","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2026.09.022_bib75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1471-4159.2006.04052.x","article-title":"Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4\/p38delta or JNK2 in the presence of heparin generates the AT100 epitope","volume":"99","author":"Yoshida","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2026.09.022_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110366","article-title":"Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involvement of nitric oxide status, Abeta extrusion transporter ABCB1, and reversal by PKA inhibitor H89","volume":"111","author":"Ashour","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ymthe.2026.09.022_bib77","doi-asserted-by":"crossref","first-page":"L493","DOI":"10.1152\/ajplung.00431.2009","article-title":"Protein kinase A phosphorylation of tau-serine 214 reorganizes microtubules and disrupts the endothelial cell barrier","volume":"299","author":"Zhu","year":"2010","journal-title":"Am. J. Physiology-Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib78","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.123.21356","article-title":"Hypertension, Neurodegeneration, and Cognitive Decline","volume":"81","author":"Pacholko","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.ymthe.2026.09.022_bib79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fimmu.2018.00679","article-title":"Wnt5A Signaling Promotes Defense Against Bacterial Pathogens by Activating a Host Autophagy Circuit","volume":"9","author":"Jati","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib80","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nprot.2016.015","article-title":"Using single nuclei for RNA-seq to capture the transcriptome of postmortem neurons","volume":"11","author":"Krishnaswami","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.09.022_bib81","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.cell.2021.04.021","article-title":"A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation","volume":"184","author":"Yao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.022_bib82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41587-021-01206-w","article-title":"A Python library for probabilistic analysis of single-cell omics data","volume":"40","author":"Gayoso","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib83","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41587-023-01733-8","article-title":"The scverse project provides a computational ecosystem for single-cell omics data analysis","volume":"41","author":"Virshup","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.022_bib84","doi-asserted-by":"crossref","DOI":"10.3791\/55523","article-title":"Assessment of spontaneous alternation, novel object recognition and limb clasping in transgenic mouse models of amyloid-beta and tau neuropathology","author":"Miedel","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2026.09.022_bib85","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0006-8993(92)91352-F","article-title":"A two-trial memory task with automated recording: study in young and aged rats","volume":"588","author":"Dellu","year":"1992","journal-title":"Brain Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:25:38Z","timestamp":1791231938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":85,"alternative-id":["S1525001626007926"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catestatin peptide ameliorates tauopathy and amyloidogenesis via adrenergic inhibition","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}